TeselaGen Biotechnology develops DNA design and assembly tools for biology.
Business Model:
Revenue: $4.5M
Employees: 51-200
Address: 1501 Mariposa St Suite 312
City: San Francisco
State: CA
Zip: 94107
Country: US
TeselaGen Biotechnology develops DNA design and assembly tools for biology. It offers a cloud based solution for combinatorial gene design and editing. Its solutions include Graphical Sequence Editor to visualize, edit, and annotate gene and plasmid libraries; Symbolic CAD/CAM to piece together novel constructs using parts from its database; Fabrication Intelligence to generate protocols that are optimized for cost, and verified to assemble quickly and accurately; and Validation to align sequence traces with design variants. Michael Fero, Eduardo Abeliuk, and Nathan Hillson founded TeselaGen on June 1, 2011. It has its headquarters in San Francisco in California.
Contact Phone:
+16503875932
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2012 | Grant | 1 | $180k |
National Science Foundation National Science Foundation National Science Foundation |
1/2013 | Grant | 1 | $150k |
National Science Foundation National Science Foundation National Science Foundation |
2/2017 | Grant | 1 | $500k |
Small Business Innovation Research Small Business Innovation Research |
9/2014 | Grant | 1 | $1.3M |
National Science Foundation National Science Foundation National Science Foundation |
1/2018 | Venture Round | $2M | 10/2020 | Seed Round | 1 | - |
Propel(X) Propel(X) |
10/2020 | Seed Round | 1 | - |
Propel(X) Propel(X) |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|